UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO)
OFFICE ACTION (OFFICIAL LETTER) ABOUT APPLICANT’S TRADEMARK APPLICATION
|
APPLICATION SERIAL NO. 85442528
APPLICANT: Cerulean Pharma Inc.
|
|
|
CORRESPONDENT’S ADDRESS: |
|
|
MARK: CERULEAN
|
|
|
CORRESPONDENT’S REFERENCE/DOCKET NO. TPHA 1104692
CORRESPONDENT’S EMAIL ADDRESS: |
|
ISSUE/MAILING DATE: 8/9/2012
Serial Number 85442528
The request to divide application serial no. 85442528 filed on July 24, 2012 has been processed as follows:
(1) Parent (original) application serial no. 85442528 contains the following goods in class(es): 5 pharmaceutical preparations for use in the diagnosis, prognosis or prevention of oncological diseases or disorders, including malignant cancers or neoplasms; pharmaceutical preparations for use in the diagnosis, prognosis, prevention or treatment of oncological diseases or disorders, including pre-cancerous diseases or disorders and benign cancers or neoplasms, inflammation and inflammatory diseases or disorders, and cardiovascular diseases or disorders; pharmaceutical preparations for use in modulating angiogenesis; pharmaceutical preparations for use in the diagnosis, prognosis and prevention of oncological diseases or disorders, including malignant cancers or neoplasms, all containing nanometer size compounds which facilitate targeting or delivery of the active ingredient; pharmaceutical preparations for use in the diagnosis, prognosis, prevention or treatment of oncological diseases or disorders, including pre-cancerous diseases or disorders and benign cancers or neoplasms, inflammation and inflammatory diseases or disorders, and cardiovascular diseases or disorders, all containing nanometer size compounds which facilitate targeting or delivery of the active ingredient; pharmaceutical preparations for use in modulating angiogenesis, containing nanometer size compounds which facilitate targeting or delivery of the active ingredient. To avoid abandonment, applicant must continue to file requests for extension of time to file a statement of use (extension requests) or a statement of use within the six-month period after the issuance of the notice of allowance or before expiration of a previously granted extension period. 37 C.F.R. §§2.88(a), 2.89(a)-(b).
(2) Child application serial no. 85977241 contains the following goods in class(es): 5 pharmaceutical preparations for use in the treatment of oncological diseases or disorders, including malignant cancers or neoplasms; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in the treatment of oncological diseases or disorders, including malignant cancers or neoplasms, all containing nanometer size compounds which facilitate targeting or delivery of the active ingredient; pharmaceutical preparations for use in chemotherapy, containing nanometer size compounds which facilitate targeting or delivery of the active ingredient. A statement of use filed on July 24, 2012 has been placed in the child application and routed to the examining attorney for examination.
37 C.F.R. §2.87; see TMEP §§1110 et seq.
Please call the undersigned with any questions.
/Antoinette Torregano/
Antoinette Torregano
Paralegal Specialist
ITU/Divisional Unit
Telephone # 571 272-9514
Fax # 571 273-9514
NO RESPONSE TO THIS NOTICE IS REQUIRED.
PERIODICALLY CHECK THE STATUS OF THE APPLICATION: To ensure that applicant does not miss crucial deadlines or official notices, check the status of the application every three to four months using Trademark Applications and Registrations Retrieval (TARR) at http://tarr.gov.uspto.report/. Please keep a copy of the complete TARR screen. If TARR shows no change for more than six months, call 1-800-786-9199. For more information on checking status, see http://www.gov.uspto.report/trademarks/process/status/.
TO UPDATE CORRESPONDENCE/E-MAIL ADDRESS: Use the TEAS form at http://www.gov.uspto.report/teas/eTEASpageE.htm.
FOR INQUIRIES OR QUESTIONS ABOUT THIS OFFICE ACTION, PLEASE CONTACT THE ASSIGNED ITU STAFF MEMBER IDENTIFIED ABOVE.